Close

Articles Posted in Sarcoma Cancer

Updated:

J & J Ethicon Stops Hysterectomy Power Morcellators Over Cancer Risk

Johnson & Johnson’s Ethicon subsidiary has announced that it will stop selling its power morcellators used for uterine fibroid removal surgery. Medical research has shown that use of the devices during minimally invasive laparoscopic hysterectomy and myomectomy procedures may carry a risk of spreading sarcoma cancer. Johnson & Johnson Ethicon:…

Contact Us
Start Chat